Refine
Has Fulltext
- yes (22)
Is part of the Bibliography
- yes (22)
Year of publication
Document Type
- Journal article (22)
Language
- English (22)
Keywords
- inflammation (6)
- Ureaplasma parvum (4)
- monocytes (4)
- Medizin (3)
- Ureaplasma urealyticum (3)
- cytokines (3)
- endothelial cells (3)
- HBMEC (2)
- bronchopulmonary dysplasia (2)
- cord blood (2)
- flow cytometry (2)
- glucocorticoids (2)
- meningitis (2)
- neuroinflammation (2)
- preterm birth (2)
- preterm infants (2)
- protein expression (2)
- surfactants (2)
- Apoptosis (1)
- B4GALT7 gene (1)
- Bronchopulmonary dysplasia (1)
- CCN2 (1)
- CNS integrity (1)
- CTGF (1)
- Caspase (1)
- Exercise capacity (1)
- Exercise testing (1)
- H441 (1)
- IMR-90 (1)
- Meningitis (1)
- Mucopolysaccharidosis IIIa (1)
- Neuroinflammation (1)
- Physical activity (1)
- Preterm birth (1)
- RNA isolation (1)
- SIRP-alpha (1)
- T cells (1)
- Toll-like receptor signaling (1)
- Ureaplasma (1)
- Ureaplasma species (1)
- VLBW (1)
- adults (1)
- airway remodeling (1)
- alveolar epithelium in vitro model, claudin-1, claudin-3, claudin-4, claudin-5 (1)
- angiogenesis (1)
- animal model (1)
- anti inflammation (1)
- apoptosis (1)
- atypical chemokine receptor 3 (1)
- barrier (1)
- blood–brain barrier (1)
- bronchopulmonary dysplasia (BPD) (1)
- caffeine (1)
- case report (1)
- cells (1)
- central nervous system (1)
- chorioamnionitis (1)
- cloning (1)
- connective tissue disorder (1)
- continuous positive airway pressure (CPAP) (1)
- corticosteroids (1)
- diagnostic delay (1)
- drug therapy (1)
- early onset sepsis (1)
- exposure (1)
- expression (1)
- fetal lung (1)
- fibrosis (1)
- genotype-phenotype correlation (1)
- human brain microvascular endothelial cells (1)
- human monocytes (1)
- immaturity (1)
- immunomodulation (1)
- in vitro (1)
- infection (1)
- innate immunity (1)
- late onset sepsis (1)
- lung (1)
- lung injury (1)
- lymphocytes (1)
- messenger RNA (1)
- monocyte subsets (1)
- mouse models (1)
- neonatal immunology (1)
- neonatal meningitis (1)
- neonatal morbidity (1)
- neonatal outcome (1)
- non-invasive respiratory support (1)
- non-invasive ventilation (1)
- p.R245H (1)
- p.S298P (1)
- pregnancy (1)
- preterm (1)
- preterm infant (1)
- rat (1)
- resolution (1)
- respiratory distress syndrome (RDS) (1)
- respiratory-distress-syndrome (1)
- sheep (1)
- spondylodysplastic Ehlers-Danlos syndrome (1)
- streptococci (1)
- surfactant (1)
- surfactant protein-A (1)
- sustained lung inflation (SLI) (1)
- synthetic surfactant (1)
- tight junctions (1)
Institute
- Kinderklinik und Poliklinik (20)
- Neurologische Klinik und Poliklinik (5)
- Institut für Hygiene und Mikrobiologie (4)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (4)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (3)
- Institut für Humangenetik (2)
- Institut für Klinische Biochemie und Pathobiochemie (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Frauenklinik und Poliklinik (1)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 241778 (2)
- HEALTH-F2-2009-241778 (1)
Synergistic Effect of Caffeine and Glucocorticoids on Expression of Surfactant Protein B (SP-B) mRNA
(2012)
Administration of glucocorticoids and caffeine is a common therapeutic intervention in the neonatal period, but possible interactions between these substances are still unclear. The present study investigated the effect of caffeine and different glucocorticoids on expression of surfactant protein (SP)-B, crucial for the physiological function of pulmonary surfactant. We measured expression levels of SP-B, various SP-B transcription factors including erythroblastic leukemia viral oncogene homolog 4 (ErbB4) and thyroid transcription factor-1 (TTF-1), as well as the glucocorticoid receptor (GR) after administering different doses of glucocorticoids, caffeine, cAMP, or the phosphodiesterase-4 inhibitor rolipram in the human airway epithelial cell line NCI-H441. Administration of dexamethasone (1 mM) or caffeine (5 mM) stimulated SP-B mRNA expression with a maximal of 38.8611.1-fold and 5.261.4-fold increase, respectively. Synergistic induction was achieved after coadministration of dexamethasone (1 mM) in combination with caffeine (10 mM) (206659.7-fold increase, p,0.0001) or cAMP (1 mM) (2136111-fold increase, p = 0.0108). SP-B mRNA was synergistically induced also by administration of caffeine with hydrocortisone (87.9639.0), prednisolone (154666.8), and betamethasone (12366.4). Rolipram also induced SP-B mRNA (64.9621.0-fold increase). We detected a higher expression of ErbB4 and GR mRNA (7.0- and 1.7-fold increase, respectively), whereas TTF-1, Jun B, c-Jun, SP1, SP3, and HNF-3a mRNA expression was predominantly unchanged. In accordance with mRNA data, mature SP-B was induced significantly by dexamethasone with caffeine (13.869.0-fold increase, p = 0.0134). We found a synergistic upregulation of SP-B mRNA expression induced by co-administration of various glucocorticoids and caffeine, achieved by accumulation of intracellular cAMP. This effect was mediated by a caffeinedependent phosphodiesterase inhibition and by upregulation of both ErbB4 and the GR. These results suggested that caffeine is able to induce the expression of SP-transcription factors and affects the signaling pathways of glucocorticoids, amplifying their effects. Co-administration of caffeine and corticosteroids may therefore be of benefit in surfactant homeostasis.
Early onset sepsis due to group B streptococcus leads to neonatal morbidity, increased mortality, and long-term neurological deficencies. Interaction between septicemic GBS and confluent monolayers of human coronary artery endothelial cells (HCAECs) was analyzed by genome wide expression profiling. In total, 124 genes were differentially expressed (89 upregulated, 35 downregulated) based on a more than 3-fold difference to control HCAEC. Regulated genes are involved in apoptosis, hemostasis, oxidative stress response, infection, and inflammation. Regulation of selected genes and proteins identified in the gene array analysis was confirmed by Real-time RT-PCR assay (granulocy te chemotactic protein 2), ELISA (urokinase, cyclooxygenase 2, granulocyte chemotactic protein 1), and western blotting (Heme oxygenase1, BCL2 interacting protein) at various time points between 4 and 24 hours. These results indicate that GBS infection might influence signalling pathways leading to impaired function of the innate immune system and hemorrhagic and inflammatory complications during GBS sepsis.